Search

Your search keyword '"Thouvenin, Guillaume"' showing total 191 results

Search Constraints

Start Over You searched for: Author "Thouvenin, Guillaume" Remove constraint Author: "Thouvenin, Guillaume"
191 results on '"Thouvenin, Guillaume"'

Search Results

1. The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study

3. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study

4. The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTRvariant: a real-world study

5. Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients

6. TTC12 Loss-of-Function Mutations Cause Primary Ciliary Dyskinesia and Unveil Distinct Dynein Assembly Mechanisms in Motile Cilia Versus Flagella

7. Beyond Kaftrio : mechanistic insights to maximize N1303K-CFTR rescue

8. Skewed X-chromosome inactivation drives the proportion of DNAAF6-defective airway motile cilia and variable expressivity in primary ciliary dyskinesia.

11. Behavioural and sleep issues after initiation of elexacaftor–tezacaftor–ivacaftor in preschool-age children with cystic fibrosis

12. Variability of lung function in patients with primary ciliary dyskinesia (PCD): longitudinal analysis from the PROVALF-PCD cohort, a BEAT-PCD Collaboration

13. Lung function and airway microbiology in primary ciliary dyskinesia (PCD): cross-sectional analysis from the PROVALF-PCD cohort, a BEAT-PCD Collaboration

14. Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study

16. Prevalence and course of disease after lung resection in primary ciliary dyskinesia: a cohort & nested case-control study

19. Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN)

21. Pulmonary hemosiderosis in children with Down syndrome: a national experience

23. High Nasal Nitric Oxide, Cilia Analyses, and Genotypes in a Retrospective Cohort of Children with Primary Ciliary Dyskinesia

26. SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant

27. The disease-specific clinical trial network for primary ciliary dyskinesia: PCD-CTN

28. Lung function from school age to adulthood in primary ciliary dyskinesia

29. The disease-specific clinical trial network for primary ciliary dyskinesia:PCD-CTN

31. Lung function from school age to adulthood in primary ciliary dyskinesia

32. TTC12 loss-of-function mutations cause primary ciliary dyskinesia and unveil distinct dynein assemblymechanisms in motile cilia versus flagella

34. Lower airways clinical outcome measures for use in primary ciliary dyskinesia research, a scoping review

35. Late Breaking Abstract - Usefulness of lung ultrasound in the diagnosis and early detection of acute chest syndrome in children with sickle cell disease

37. Characteristics of disorders associated with genetic mutations of surfactant protein C

38. Lung function from school age to adulthood in primary ciliary dyskinesia

39. Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

44. Topological data analysis reveals genotype–phenotype relationships in primary ciliary dyskinesia

46. The Wide Spectrum of COVID-19 Clinical Presentation in Children

49. Registries and collaborative studies for primary ciliary dyskinesia in Europe

50. Time trends in diagnostic testing for PCD in Europe

Catalog

Books, media, physical & digital resources